Browsing by Publisher "Wiley-Blackwell Publishing Ltd."

Now showing items 1-3 of 3

    • Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 3 

      Liakina, Valentina; Hamid, S.; Tanaka, J.; Speičienė, Danutė Marija; Valantinas, Jonas; Olafsson, S.; Sharara, A.I.; Alavian, S.M.; Gheorghe, L.; El Hassan, E.S.; Abaalkhail, F.; Abbas, Z.; Abdou, A.; Abourached, A.; Al Braiki, F.; Al Hosani, F.; Al Jaberi, K.; Al Khatry, M.; Al Mulla, M.A.; Al Quraishi, H.; Al Rifai, A.; Al Serkal, Y.; Alam, A.; Alashgar, H.I.; Alawadhi, S.; Al-Dabal, L.; Aldins, P.; Alfalech, F.Z.; Alghamdi, A.S.; Al-Hakeem, R.; Aljumah, A.A.; Almessabi, A.; Alqutub, A.N.; Alswat, K.A.; Altraif, I.; Alzaabi, M.; Andrea, N.; Assiri, A.M.; Babatin, M.A.; Baqir, A.; Barakat, M.T.; Bergmann, O.M.; Bizri, A.R.; Blach, S.; Chaudhry, A.; Choi, M.S.; Diab, T.; Djauzi, S.; El Khoury, S.; Estes, C.; Fakhry, S.; Farooqi, J.I.; Fridjonsdottir, H.; Gani, R. A.; Khan, A. Ghafoor; Goldis, A.; Gottfredsson, M.; Gregorcic, S.; Hajarizadeh, B.; Han, K.H.; Hasan, I.; Hashim, A.; Horvath, G.; Hunyady, B.; Hunsi, R.; Jafri, W.; Jeruma, A.; Jonasson, J.G.; Karlsdottir, B.; Kim, D.Y.; Kim, Y.S.; Koutoubi, Z.; Lesmana, L.A.; Lim, Y.S.; Love, A.; Maimets, M.; Makara, M.; Malekzadeh, R.; Maticic, M.; Memon, M.S.; Merat, S.; Mokhbat, J.E.; Mourad, F. H.; Muljono, D.H.; Nawaz, A.; Nugrahini, N.; Priohutomo, S.; Qureshi, H.; Rassam, P.; Razavi, H.; Razavi-Shearer, D.; Razavi-Shearer, K.; Rozentale, B.; Sadik, M.; Saeed, K.; Salamat, A.; Salupere, R.; Sanai, F.M.; Sulaiman, A.; Sayegh, R.A.; Schmelzer, J.D.; Sibley, A.; Siddiq, M.; Siddiqui, A.M.; Sigmundsdottir, G.; Sigurdardottir, B.; Sultan, M. A.; Taha, M.; Tarifi, H.; Tayyab, G.; Tolmane, I.; Din, M.Ud; Umar, M.; Videcnik-Zorman, J.; Yaghi, C.; Yunihastuti, E.; Yusuf, M.A.; Zuberi, B.F.; Gunter, J. (Journal of viral hepatitis, 2015)
      Detailed, country-specific epidemiological data are needed to characterize the burden of chronic hepatitis C virus (HCV) infection around the world. With new treatment options available, policy makers and public health ...

    • Strategies to manage hepatitis C virus infection disease burden – volume 3 

      Alfaleh, F.Z.; Nugrahini, N.; Matičič, M.; Valantinas, Jonas; Liakina, Valentina; Speičienė, Danutė Marija; Tolmane, I.; Alzaabi, M.; Hajarizadeh, B.; Kim, D.Y.; Hunyady, B.; Abaalkhail, F.; Abbas, Z.; Abdou, A.; Abourached, A.; Al Braiki, F.; Al Hosani, F.; Al Jaberi, K.; Al Khatry, M.; Al Mulla, MA; Al Quraishi, H.; Al Rifai, A.; Al Serkal, Y.; Alam, A.; Alashgar, H.I.; Alavian, S.M.; Alawadhi, S.; Al-Dabal, L.; Aldins, P.; Alghamdi, A.S.; Al-Hakeem, R.; Aljumah, A.A.; Almessabi, A.; Alqutub, A.N.; Alswat, K.A.; Altraif, I.; Andrea, N.; Assiri, A.M.; Babatin, M.A.; Baqir, A.; Barakat, M.T.; Bergmann, O.M.; Bizri, A.R.; Chaudhry, A.; Choi, M.S.; Diab, T.; Djauzi, S.; El Hassan, E.S.; El Khoury, S.; Estes, C.; Fakhry, S.; Farooqi, J.I.; Fridjonsdottir, H.; Gani, R.A.; Khan, A.Ghafoor; Gheorghe, L.; Goldis, A.; Gottfredsson, M.; Gregorcic, S.; Gunter, J.; Hamid, S.; Han, K.H.; Hasan, I.; Hashim, A.; Horvath, G.; Husni, R.; Jafri, W.; Jeruma, A.; Jonasson, J.G.; Karlsdottir, B.; Kim, Y.S.; Koutoubi, Z.; Lesmana, L.A.; Lim, Y.S.; Love, A.; Maimets, M.; Makara, M.; Malekzadeh, R.; Memon, M.S.; Merat, S.; Mokhbat, J.E.; Mourad, F.H.; Muljono, D.H.; Nawaz, A.; Olafsson, S.; Priohutomo, S.; Qureshi, H.; Rassam, P.; Razavi, H.; Razavi-Shearer, D.; Razavi-Shearer, K.; Rozentale, B.; Sadik, M.; Saeed, K.; Salamat, A.; Salupere, R.; Sanai, F. M.; Sulaiman, A. Sanityoso; Sayegh, R. A.; Schmelzer, J.D.; Sharara, A.I.; Sibley, A.; Siddiq, M.; Siddiqui, A. M.; Sigmundsdottir, G.; Sigurdardottir, B.; Sulaiman, A.; Sultan, M.A.; Taha, M.; Tanaka, J.; Tarifi, H.; Tayyab, G.; Din, M.Ud; Umar, M.; Videcnik-Zorman, J.; Yaghi, C.; Yunihastuti, E.; Yusuf, M.A.; Zuberi, B.F.; Blach, S. (Journal of viral hepatitis, 2015)
      The hepatitis C virus (HCV) epidemic was forecasted through 2030 for 15 countries in Europe, the Middle East and Asia, and the relative impact of two scenarios was considered: [1] increased treatment efficacy while holding ...

    • The case for simplifying and using absolute targets for viral hepatitis elimination goals 

      Razavi, Homie; Blach, Sarach; Razavi‐Shearer, Devin; Liakina, Valentina; Valantinas, Jonas (Journal of viral hepatitis, 2021)
      The 69th World Health Assembly endorsed the Global Health Sector Strategy for Viral Hepatitis, embracing a goal to eliminate hepatitis infection as a public health threat by 2030. This was followed by the World Health ...